- Home
- IMMR vs ENGN Comparison
IMMR vs ENGN Comparison
Compare IMMR & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMR
- ENGN
- Stock Information
- Founded
- IMMR 1993
- ENGN 1999
- Country
- IMMR United States
- ENGN Canada
- Employees
- IMMR N/A
- ENGN N/A
- Industry
- IMMR Computer peripheral equipment
- ENGN
- Sector
- IMMR Technology
- ENGN
- Exchange
- IMMR Nasdaq
- ENGN Nasdaq
- Market Cap
- IMMR 271.9M
- ENGN 293.1M
- IPO Year
- IMMR 1999
- ENGN N/A
- Fundamental
- Price
- IMMR $8.97
- ENGN $7.90
- Analyst Decision
- IMMR Strong Buy
- ENGN Strong Buy
- Analyst Count
- IMMR 1
- ENGN 6
- Target Price
- IMMR $13.50
- ENGN $33.67
- AVG Volume (30 Days)
- IMMR 465.8K
- ENGN 135.1K
- Earning Date
- IMMR 11-15-2024
- ENGN 09-10-2024
- Dividend Yield
- IMMR 2.01%
- ENGN N/A
- EPS Growth
- IMMR 57.07
- ENGN N/A
- EPS
- IMMR 2.04
- ENGN N/A
- Revenue
- IMMR $163,133,000.00
- ENGN N/A
- Revenue This Year
- IMMR $988.71
- ENGN N/A
- Revenue Next Year
- IMMR $88.38
- ENGN N/A
- P/E Ratio
- IMMR $4.38
- ENGN N/A
- Revenue Growth
- IMMR 338.21
- ENGN N/A
- 52 Week Low
- IMMR $5.94
- ENGN $4.42
- 52 Week High
- IMMR $13.94
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- IMMR 51.53
- ENGN 45.34
- Support Level
- IMMR $8.36
- ENGN $8.50
- Resistance Level
- IMMR $8.86
- ENGN $9.06
- Average True Range (ATR)
- IMMR 0.25
- ENGN 0.69
- MACD
- IMMR 0.02
- ENGN -0.16
- Stochastic Oscillator
- IMMR 54.67
- ENGN 3.57
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.